Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Cognitive Behavioral Therapy for Treatment of Pathological Gambling

This study has been completed.
Sponsor:
Collaborator:
Information provided by:
University of Connecticut Health Center
ClinicalTrials.gov Identifier:
NCT00158314
First received: September 7, 2005
Last updated: June 28, 2013
Last verified: June 2013

September 7, 2005
June 28, 2013
March 1998
November 2003   (final data collection date for primary outcome measure)
  • Addiction Severity Index (ASI) gambling severity scores
  • time spent gambling
  • days of non-gambling
Same as current
Complete list of historical versions of study NCT00158314 on ClinicalTrials.gov Archive Site
  • Psychiatric symptoms
  • psychosocial functioning
Same as current
Not Provided
Not Provided
 
Cognitive Behavioral Therapy for Treatment of Pathological Gambling
Cognitive Behavioral Treatment for Pathological Gambling

This study will determine the effectiveness and cost-effectiveness of three different treatment strategies in reducing gambling behaviors.

The number of pathological gamblers in the United States is steadily growing, leading to significant financial, psychological, and public health consequences. However, studies examining the effectiveness of treatment interventions for pathological gamblers are limited. This study will compare the effectiveness of three different treatment strategies, including referral to Gambler's Anonymous (GA), a self-help manual, and cognitive behavioral therapy (CBT), in reducing gambling behaviors and other problems related to pathological gambling.

This study will last 8 weeks. Participants will be randomly assigned to one of three interventions. Group 1 participants will be referred to GA and 8 weeks of CBT, which focuses on teaching skills to help reduce gambling urges and develop alternative behaviors to gambling. Group 2 participants will be referred to GA and given an 8-week self-help manual. Group 3 participants will be referred to GA alone. Questionnaires will be used to assess participants' gambling behavior and any personal, legal, or health problems they may be experiencing. The questionnaires will be completed at study entry, study completion, and at 6- and 12-month follow-up visits.

Participants will be asked to identify at least one person who knows about their gambling problem and will have regular contact with them during the study and for at least 1 year This person will be interviewed at the beginning of the study, and at Months 2, 6 and 12. Researchers will ask contact persons about participants' gambling behaviors, personal relationships, legal problems, use of health care and mental health services, and how the participant can be contacted if he or she moves.

For information on related studies, please follow these links:

http://clinicaltrials.gov/show/NCT00118391

http://clinicaltrials.gov/show/NCT00618462

Interventional
Phase 1
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Gambling
  • Behavioral: Referral to Gamblers Anonymous
  • Behavioral: Cognitive behavioral therapy
  • Behavioral: Cognitive behavioral self-help manual
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
231
November 2003
November 2003   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Diagnosis of pathological gambling
  • 3 or more gambling episodes within 60 days prior to study entry

Exclusion Criteria:

  • Inability to read English at the 5th grade level
  • Uncontrolled psychiatric condition
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00158314
R01 MH060417-01, R01MH060417-01, DATR A2-AIR
Yes
Nancy Petry, PhD, University of Connecticut Health Center
University of Connecticut Health Center
National Institute of Mental Health (NIMH)
Principal Investigator: Nancy M. Petry, PhD University of Connecticut Health Center
University of Connecticut Health Center
June 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP